|
Real-time Estimate
Cboe Europe
07:50:52 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 111.80 GBX | +0.72% |
|
+2.95% | +15.73% |
| 08-24 | JPMorgan raises Diploma, Barclays cuts Unite | AN |
| 08-14 | UBS raises Michael Page to 'buy' | AN |
| Fiscal Period: December | 2016 (GBP) | 2017 (GBP) | 2018 (GBP) | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) | 2023 (GBP) | 2024 (GBP) | 2025 (GBP) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.64 | 0.19 | 1.5 | 1.71 | 1.45 | |||||
Return on Total Capital | 3.4 | 0.24 | 1.92 | 2.18 | 1.75 | |||||
Return On Equity % | 4.54 | -6.02 | 1.71 | 4.26 | 0.78 | |||||
Return on Common Equity | 4.42 | -6.94 | 1.71 | 4.26 | 0.78 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 8.74 | 7.43 | 44.83 | 45.34 | 43.68 | |||||
SG&A Margin | 0.06 | 0 | 0.09 | 0.17 | 0 | |||||
EBITDA Margin % | 11.99 | 8.97 | 13.44 | 12.3 | 11.23 | |||||
EBITA Margin % | 8.18 | 4.85 | 9.93 | 9.13 | 7.95 | |||||
EBIT Margin % | 5.57 | 0.98 | 5.44 | 4.66 | 3.71 | |||||
Income From Continuing Operations Margin % | 2.95 | -9.2 | 1.83 | 3.84 | 0.7 | |||||
Net Income Margin % | 2.8 | -55.64 | 1.71 | 3.51 | 0.7 | |||||
Net Avail. For Common Margin % | 2.8 | -10.45 | 1.83 | 3.84 | 0.7 | |||||
Normalized Net Income Margin | 2.3 | -3.92 | 2.71 | 0.85 | 0.48 | |||||
Levered Free Cash Flow Margin | 2.26 | 29.85 | -2.25 | -8.44 | 10.09 | |||||
Unlevered Free Cash Flow Margin | 3.14 | 32.54 | -0.71 | -6.61 | 12.02 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.31 | 0.44 | 0.59 | 0.62 | |||||
Fixed Assets Turnover | 3.1 | 1.73 | 3.47 | 3.2 | 3.33 | |||||
Receivables Turnover (Average Receivables) | 6.84 | 3.48 | 7.12 | 7.46 | 7.49 | |||||
Inventory Turnover (Average Inventory) | 7.57 | 3.23 | 2.69 | 2.49 | 2.49 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.05 | 1.55 | 1.65 | 2.28 | 2.2 | |||||
Quick Ratio | 1.42 | 1.36 | 1.05 | 1.21 | 1.18 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | 0.18 | 0.26 | 0.35 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 53.36 | 104.83 | 51.24 | 49.08 | 48.71 | |||||
Days Outstanding Inventory (Average Inventory) | 48.2 | 113.01 | 135.65 | 146.8 | 146.56 | |||||
Average Days Payable Outstanding | 38.77 | 99.05 | 58.35 | 53.65 | 57.88 | |||||
Cash Conversion Cycle (Average Days) | 62.79 | 118.79 | 128.53 | 142.23 | 137.39 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 58.99 | 78.17 | 46.27 | 50.44 | 47.67 | |||||
Total Debt / Total Capital | 37.1 | 43.88 | 31.63 | 33.53 | 32.28 | |||||
LT Debt/Equity | 57.15 | 25.49 | 43.67 | 47.23 | 44.85 | |||||
Long-Term Debt / Total Capital | 35.94 | 14.31 | 29.85 | 31.39 | 30.37 | |||||
Total Liabilities / Total Assets | 50.94 | 54.77 | 49.03 | 45.18 | 43.96 | |||||
EBIT / Interest Expense | 3.52 | 0.15 | 2.21 | 1.53 | 1.14 | |||||
EBITDA / Interest Expense | 8.36 | 1.62 | 6.21 | 4.73 | 4.09 | |||||
(EBITDA - Capex) / Interest Expense | 5.83 | -0.17 | 4.62 | 3.43 | 3.01 | |||||
Total Debt / EBITDA | 2.92 | 8.8 | 2.61 | 3.14 | 3.16 | |||||
Net Debt / EBITDA | 1.85 | -2.94 | 1.38 | 2.37 | 2.26 | |||||
Total Debt / (EBITDA - Capex) | 4.19 | -83.13 | 3.51 | 4.32 | 4.3 | |||||
Net Debt / (EBITDA - Capex) | 2.65 | 27.76 | 1.85 | 3.26 | 3.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.05 | 12 | -6.39 | -4.39 | -0.13 | |||||
Gross Profit, 1 Yr. Growth % | 34.67 | -4.92 | -4.32 | -3.31 | -3.79 | |||||
EBITDA, 1 Yr. Growth % | 24.43 | -28.54 | 53.43 | 10.39 | -13.96 | |||||
EBITA, 1 Yr. Growth % | 42.21 | -45.52 | 127.54 | 22.12 | -19.46 | |||||
EBIT, 1 Yr. Growth % | 77.74 | -82.54 | 2.36K | 67.86 | -31.29 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -1.99K | 534.69 | -118.65 | 100 | -81.9 | |||||
Net Income, 1 Yr. Growth % | -915.15 | -798.88 | -102.87 | 96.3 | -80.19 | |||||
Normalized Net Income, 1 Yr. Growth % | 189.36 | -1.04K | -150.7 | -16.33 | -63.49 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -835.48 | 460.13 | -116.79 | 103.18 | -82.5 | |||||
Accounts Receivable, 1 Yr. Growth % | 12.9 | -69.56 | -3.97 | -13.56 | 14.36 | |||||
Inventory, 1 Yr. Growth % | 25.44 | -49.5 | -0.46 | 4.95 | 1.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.33 | -71.71 | 11.37 | -3.33 | -4.53 | |||||
Total Assets, 1 Yr. Growth % | 2.39 | -30.31 | -40 | -7.84 | -3.91 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.3 | 52.86 | -70.53 | 13.06 | 8.97 | |||||
Common Equity, 1 Yr. Growth % | 1.32 | -34.05 | -32.39 | -0.88 | -1.77 | |||||
Cash From Operations, 1 Yr. Growth % | -31.9 | 1.27 | -53.91 | -12.88 | -1.17 | |||||
Capital Expenditures, 1 Yr. Growth % | 24.6 | 3.12 | -68.77 | -4.03 | -10.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -65.02 | -373.58 | -107.27 | 102.28 | -226.13 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -57.14 | -471.65 | -102.1 | 157.9 | -295.03 | |||||
Dividend Per Share, 1 Yr. Growth % | 81.82 | -45 | 9.09 | -22.22 | -28.57 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.74 | -38.61 | 2.39 | -5.4 | -2.29 | |||||
Gross Profit, 2 Yr. CAGR % | -2.08 | -36.53 | 131.76 | -3.82 | -3.55 | |||||
EBITDA, 2 Yr. CAGR % | -3.34 | -42.77 | 0.12 | 15.89 | 0.3 | |||||
EBITA, 2 Yr. CAGR % | -5.39 | -45.49 | 2.14 | 41.42 | 3.05 | |||||
EBIT, 2 Yr. CAGR % | -8.5 | -66.89 | -4.6 | 348.81 | 15.47 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -17.12 | 355.34 | 8.8 | -38.93 | -39.83 | |||||
Net Income, 2 Yr. CAGR % | -16.3 | 654.78 | -55.2 | -76.26 | -37.64 | |||||
Normalized Net Income, 2 Yr. CAGR % | -11.96 | 31.78 | 146.21 | -61.05 | -31.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -21.66 | 211.26 | -3.01 | -41.59 | -40.37 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.1 | -41.37 | -45.93 | -8.89 | -0.58 | |||||
Inventory, 2 Yr. CAGR % | 6.67 | -20.41 | -29.1 | 2.21 | 3.04 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2.33 | -47.7 | -43.87 | 3.76 | -3.93 | |||||
Total Assets, 2 Yr. CAGR % | 3.09 | -15.53 | -35.34 | -25.64 | -5.89 | |||||
Tangible Book Value, 2 Yr. CAGR % | 66.15 | 38.95 | -32.88 | -42.28 | 10.99 | |||||
Common Equity, 2 Yr. CAGR % | 7.21 | -18.25 | -33.22 | -18.14 | -1.33 | |||||
Cash From Operations, 2 Yr. CAGR % | -9.05 | -16.95 | -31.68 | -36.63 | -7.21 | |||||
Capital Expenditures, 2 Yr. CAGR % | -10.81 | 13.35 | -43.25 | -45.25 | -7.54 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -45.32 | 27.4 | -56.04 | -48.96 | 55.37 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -39.13 | 25.06 | -72.42 | -56.81 | 116.42 | |||||
Dividend Per Share, 2 Yr. CAGR % | -2.41 | 0 | -22.54 | -7.89 | -25.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.19 | -29.74 | -29.34 | 0.08 | -3.67 | |||||
Gross Profit, 3 Yr. CAGR % | -2.56 | -34.05 | 31.54 | 73.17 | -3.81 | |||||
EBITDA, 3 Yr. CAGR % | -2.97 | -37.35 | -22.84 | -4.27 | 6.96 | |||||
EBITA, 3 Yr. CAGR % | -4.67 | -42.82 | -17.14 | -2.85 | 20.26 | |||||
EBIT, 3 Yr. CAGR % | -7.41 | -62.76 | -17.02 | -9.3 | 151.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.24 | -8.95 | 56.96 | 33.28 | -59.28 | |||||
Net Income, 3 Yr. CAGR % | 3.45 | 69.8 | 17.84 | -26.69 | -77.65 | |||||
Normalized Net Income, 3 Yr. CAGR % | -11.5 | -22.52 | 3.88 | 21.96 | -56.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -1.1 | -6.84 | 17.61 | 24.1 | -60.91 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.27 | -31.35 | -30.89 | -36.78 | -1.72 | |||||
Inventory, 3 Yr. CAGR % | 2.45 | -16.86 | -14.25 | -19.2 | 1.86 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.59 | -35.38 | -32.72 | -32.72 | 0.92 | |||||
Total Assets, 3 Yr. CAGR % | 0.25 | -9.52 | -24.63 | -27.23 | -19.01 | |||||
Tangible Book Value, 3 Yr. CAGR % | 26.12 | 61.6 | -17.14 | -20.14 | -28.66 | |||||
Common Equity, 3 Yr. CAGR % | 1.12 | -8.82 | -23.27 | -23.83 | -13.01 | |||||
Cash From Operations, 3 Yr. CAGR % | -13.92 | -5.73 | -31.75 | -25.91 | -26.51 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.87 | -6.39 | -26.24 | -32.39 | -35.61 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 36.55 | 11.53 | -51.42 | -11.52 | -32.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 26.11 | 10.57 | -68.25 | -12.26 | -30.29 | |||||
Dividend Per Share, 3 Yr. CAGR % | -33.82 | -19.39 | 2.94 | -22.43 | -15.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.79 | -19.94 | -20.96 | -20.86 | -19.56 | |||||
Gross Profit, 5 Yr. CAGR % | -5.05 | -21.57 | 9.35 | 9.4 | 16.19 | |||||
EBITDA, 5 Yr. CAGR % | -3.79 | -24.05 | -19.54 | -21.3 | -18.19 | |||||
EBITA, 5 Yr. CAGR % | -6.35 | -27.97 | -19.1 | -20.64 | -15.34 | |||||
EBIT, 5 Yr. CAGR % | -7.33 | -44.14 | -23.9 | -26.08 | -17.94 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -11.11 | 41.41 | -27.06 | -22.39 | 6.96 | |||||
Net Income, 5 Yr. CAGR % | -7.77 | 10.46 | -25.98 | -22.7 | -8.64 | |||||
Normalized Net Income, 5 Yr. CAGR % | -11.43 | -15.38 | -23.12 | -38.24 | -28.4 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -14.78 | 50.87 | -26.54 | -22.71 | -10.37 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.55 | -23.13 | -21.93 | -23.12 | -20.07 | |||||
Inventory, 5 Yr. CAGR % | 2.26 | -10.67 | -11.58 | -9.7 | -7.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.28 | -21.17 | -19.4 | -21.9 | -22.42 | |||||
Total Assets, 5 Yr. CAGR % | -1.92 | -6.34 | -15.88 | -16.35 | -17.63 | |||||
Tangible Book Value, 5 Yr. CAGR % | 56.64 | 25.05 | -2 | 7.05 | -6.86 | |||||
Common Equity, 5 Yr. CAGR % | 0.57 | -7.98 | -14.35 | -12.67 | -15.15 | |||||
Cash From Operations, 5 Yr. CAGR % | -16.21 | -3.73 | -21.52 | -19.58 | -22.83 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.1 | -3.4 | -26.6 | -24.47 | -19.26 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -16.3 | -10.97 | -3.55 | -18.88 | -13.28 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -7.85 | -9.9 | -31.6 | -24.47 | -12.39 | |||||
Dividend Per Share, 5 Yr. CAGR % | -21.94 | -30.74 | -29.52 | -14.97 | -9.53 |
- Stock Market
- Stocks
- ESNT Stock
- Financials Essentra plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















